Clinical trials
Hypoglycemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 5 |
| Medical Research Foundation, The Netherlands | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| AstraZeneca | 1 |
| Cees Tack | 1 |
| KU Leuven | 1 |
| Kim Kamphorst | 1 |
| Nutricia Research | 1 |
| Onze Lieve Vrouwe Gasthuis | 1 |
| Prof. Valérie Mc Lin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 17 |
| Diabetes Mellitus, Type 1 | 6 |
| Hyperglycemia | 5 |
| Insulin Resistance | 3 |
| Critical Illness | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hyperinsulinism | 2 |
| Adenoma, Islet Cell | 1 |
| Body Weight | 1 |
| Congenital Portosystemic Shunt | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.